Procter & Gamble insider files Form 144 to sell 3,837 shares

Rhea-AI Filing Summary

Form 144: This notice reports a proposed sale of 3,837 shares of Common Stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $583,626.89 and an approximate sale date of 10/02/2025. The securities were acquired as a Restricted Stock Unit Award from The Procter & Gamble Company on 10/03/2022 (7269 units noted). The filing also discloses a sale within the past three months: 8,596 shares sold on 08/19/2025 for gross proceeds of $1,351,925.58. The issuer's outstanding shares are listed as 2,342,371,488. The signer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small individual insider sale notice relative to total shares outstanding; routine compliance disclosure.

The Form 144 notifies the brokered intent to sell 3,837 shares valued at $583,626.89, with prior recent sale of 8,596 shares for $1,351,925.58. The shares were acquired via RSU award from the issuer on 10/03/2022. Against 2,342,371,488 shares outstanding, these transactions are immaterial to company capitalization but are relevant for monitoring insider liquidity and compliance with Rule 144 resale conditions.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; filing indicates insider is certifying absence of undisclosed material information.

The document shows the filer using a registered broker and specifying acquisition details (RSU award) and recent sales, which supports transparency and regulatory compliance. The explicit representation that no material nonpublic information is held is standard and important for governance oversight. No indications of unusual timing or clustered large disposals are present in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	3837	583626.89	2342371488	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/03/2022	Restricted Stock Unit Award	The Procter & Gamble Company			7269	10/03/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jennifer L. Davis 1 Procter & Gamble Plaza Cincinnati OH 45202	Common Stock	08/19/2025	8596	1351925.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PG disclose about the proposed sale?

The filing reports a proposed sale of 3,837 shares of Procter & Gamble common stock valued at $583,626.89, to be sold through Morgan Stanley Smith Barney LLC on or about 10/02/2025.

How and when were the securities being sold on Form 144 acquired?

The securities were acquired as a Restricted Stock Unit Award from The Procter & Gamble Company on 10/03/2022, showing 7,269 units in the acquisition record.

Did the filer sell any PG shares recently prior to this Form 144 filing?

Yes. The filing discloses a sale of 8,596 shares on 08/19/2025 for gross proceeds of $1,351,925.58, by Jennifer L. Davis at the Procter & Gamble address shown.

Who is the broker handling the proposed sale listed in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY 10004.

How many shares outstanding does the filing show for the issuer?

The filing lists 2,342,371,488 shares outstanding for the issuer.